NCT01802723 - Dose Ranging Study | Biotech Hunter

Enrollment

472

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

October 31, 2013

Conditions

Periumbilical Subcutaneous Adipose Tissue Reduction

Interventions

DRUG

Drug: salmeterol xinafoate

DRUG

Drug: Placebo

Trial Locations (22)

United States, California, Beverly Hills

United States, California, Encinitas

United States, California, Los Angeles

United States, California, San Diego

United States, California, Santa Ana

United States, Florida, Aventura

United States, Florida, Clearwater

United States, Florida, Lake Worth

United States, Florida, Miami

United States, Florida, Tampa

United States, Illinois, Buffalo Grove

United States, Illinois, Chicago

United States, New York, New York

United States, New York, Smithtown

United States, North Carolina, Chapel Hill

United States, North Carolina, Raleigh

United States, Tennessee, Nashville

United States, Texas, Austin

United States, Texas, Dallas

United States, Texas, Fort Worth

United States, Texas, Houston

United States, Texas, Plano